A misunderstood liquidation preference or a poorly drafted board seat provision is often the primary reason a founder loses control of their own company after a Series B round. Before a single wire transfer is initiated or a share certificate is issued, a company needs its financial constitution, the Investment Agreement.
While a Pitch Deck sells the vision, an Investment Agreement (whether a Stock Purchase Agreement, Convertible Note, or SAFE) dictates the reality of the partnership. It defines not just how much money comes in, but what rights, controls, and future value the investors get in return.
For high-growth startups, specifically in biotech and software development, these documents are the architecture of the Cap Table.
Fundraising rounds and future exits are frequently complicated by “cap table debt,” such as failing to calculate fully diluted shares correctly or granting veto rights to early angel investors.
In tech and life sciences, where capital intensity is high, a balanced Investment Agreement is the difference between a successful partnership and a founder being ousted from their own boardroom.
An Investment Agreement is a definitive, binding contract between the startup (Issuer) and the investor (Subscriber) that governs the purchase of equity or debt convertible into equity. Depending on the stage, this takes the form of a Stock Purchase Agreement (SPA), a Simple Agreement for Future Equity (SAFE), or a Convertible Note.
Unlike a Term Sheet, which is a non-binding summary of business points, the Investment Agreement is the legally enforceable document that actually transfers shares and wires funds. It transforms a handshake deal into a permanent corporate obligation.
In the high-stakes world, investors are professionals at protecting their downside. Startups in these fields face unique risks: a “down round” that washes out common stock, or a strategic investor blocking a pivot due to strict protective provisions.
As your Startup Governance Lawyer, Crowley Law structures investments to be equitable and to withstand the scrutiny of future lead investors.
Our investment agreements are drafted to the institutional standards that professional investors expect, ensuring your startup’s governance structure can withstand rigorous due diligence.
Custom-tailored Investment Agreements provide several critical layers of protection:
A common pitfall is assuming the deal is “done” when the Term Sheet is signed. The Term Sheet is merely the blueprint; the Investment Agreement is the house. Relying on the Term Sheet alone leaves you with no legal recourse if the investor walks away or changes the deal mechanics at the last minute.
Feature | Investment Agreement (SPA/Note/SAFE) | Term Sheet |
Primary Function | A binding contract transferring securities. | Non-binding summary of terms. |
Enforceability | High. Creates legal rights and obligations. | Low. Generally unenforceable (except confidentiality/exclusivity). |
Detail Level | Granular (Reps, Warranties, Indemnification). | High-level (Valuation, Board Seats, Liquidation Pref). |
Closing Condition | Required to trigger the wire transfer. | Precursor to drafting the real documents. |
The Investment Agreement is the rulebook for your relationship with your capital partners. It must be drafted with a long-term view, anticipating subsequent funding rounds (Series A, B, C) and an eventual IPO or acquisition.
As your Life Sciences Corporate Counsel, Crowley Law embeds durability directly into the deal.
Key components include:
Founders often think control is only at risk in later rounds, like Series B or Series C. In reality, the first priced round or convertible note often sets the rules for who controls the company, how value is distributed, and what decisions require investor approval.
Early agreements quietly dictate board composition, exit payouts, veto rights, and future financing constraints. Once these provisions enter the cap table, they are rarely removed, and their effects compound as the company grows.
Poorly structured liquidation preferences, dilution mechanics, or consent rights can drastically reduce founder ownership and flexibility even if the startup becomes highly successful.
Key terms locked in early include:
A balanced Investment Agreement protects investor downside without stripping founders of control. It sets clear rules for growth, governance, and value distribution from day one.
If the Valuation is the engine, the Investment Agreement is the steering wheel. It dictates who drives the company. Without a robust agreement, a startup risks stagnation due to shareholder deadlock.
Crowley Law’s services focus on:
These agreements are frequently treated as “standard forms” provided by the VC. This leads to “terms debt” toxic clauses that scare away future investors or crush founder returns.
Real-World Pitfalls to Avoid:
Ignoring anti-dilution protections, a broad-based weighted average is fair; a full ratchet can scare future investors.
We do not just provide documents; the firm serves as a strategic partner, understanding the high-growth trajectory of tech and life sciences. The practice combines “big firm” sophistication with a personalized, hands-on approach.
Crowley Law LLC combines decades of corporate legal experience with personalized counsel tailored to the unique needs of startups. The firm is led by Philip P. Crowley, with over 45 years of experience, including prior service as corporate counsel at Johnson & Johnson, where he managed complex internal governance and licensing matters.
Crowley Law focuses on providing strategic, practical advice that helps founders and partners build strong structures, resolve conflicts, and navigate growth smoothly.
Before you accept capital, ensure your investment governance is ironclad.
SAFEs are simpler (no maturity/interest) and dominate early-stage. Notes suitcases needing timeline certainty or debt treatment.
Yes. All securities offerings must comply with the SEC and state Blue Sky laws. Taking money from non-accredited investors requires specific exemptions (typically Rule 506(b) or 504). Violations can trigger rescission rights, fines, and enforcement actions.
Add nuance: “1x non-participating is standard in most deals; participating (double-dip) is rarer and founder-unfriendly unless negotiated in high-risk scenarios.”
It varies, but typically 0.1% to 1.0% vesting over 2 years. We use “FAST” agreement standards, but customized to protect the company’s IP.
Generally, no. Once they own stock, they are owners. This is why the “Repurchase Option” or “Buyback Right” in the Investment Agreement is critical for bad actor scenarios.
